NASDAQ: BNTC
Benitec Biopharma Inc Earnings Dates, Reports, Calls

Benitec Biopharma earnings were -$27.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest BNTC earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$9.4M, up 27.1% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, BNTC reported annual earnings of -$22.4M, with 14.4% growth.

BNTC earnings history

Current Revenue
$0.0
Current Earnings
-$27.1M
Current Profit Margin
0%

BNTC Return on Equity

Current Company
-38.1%
Current Industry
-60.2%
Current Market
31.5%
BNTC's Return on Equity (-38.1%)... subscribe to Premium to read more.
High Return on Equity Performance

BNTC undefined

Current Company
-35.5%
Current Industry
-2.5%
BNTC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BNTC announces earnings.

BNTC undefined

Current Company
-25.63%
Current Industry
5.8%
BNTC has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BNTC vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BNTC-$24.79M-$27.11MN/A$0.00
ATAI-$144.77M-$148.99MN/A-$0.91
SAGE-$353.59M-$354.40MN/A-$5.80
ERAS-$153.97M-$157.60MN/A-$0.60
ZBION/AN/AN/AN/A

Benitec Biopharma Earnings Reports & History FAQ

What were Benitec Biopharma's earnings last quarter?

On BNTC's earnings call on Invalid Date, Benitec Biopharma (NASDAQ: BNTC) reported Q1 2025 earnings per share (EPS) of -$0.00, up 0% year over year. Total BNTC earnings for the quarter were -$9.35 million. In the same quarter last year, Benitec Biopharma's earnings per share (EPS) was -$0.00.

If you're new to stock investing, here's how to buy Benitec Biopharma stock.

Is Benitec Biopharma profitable or losing money?

As of the last Benitec Biopharma earnings report, Benitec Biopharma is currently losing money. Benitec Biopharma's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$26.49 million, a 22.12% increase year over year.

What was BNTC's earnings growth in the past year?

As of Benitec Biopharma's earnings date in Invalid Date, Benitec Biopharma's earnings has grown year over year. BNTC earnings in the past year totalled -$27.11 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.